In this context, exciting studies suggest that mitochondrial damage resulting from increased ROS production could be an essential contributor to the early stages of AD before reaching the onset of clinical symptoms and the appearance of the tau and Aβ pathology [267]. Here, MAPT is linked to Alzheimer disease.